Applicability of Real-Time PCR Methodology in the Neonatal Detection of Turner Syndrome

Abstract

Turner syndrome (TS) is the complete or partial loss of the second sex chromosome, occurring in 1:5 000 girls. Early recognition allows appropriate therapy for short stature and puberty. Neonatal diagnosis of TS permits detection of associated malformations, minimizing sequels. Aiming to develop a molecular method for the diagnosis of TS we employed blood samples stored on filter paper. We evaluated 78 female controls, 25 TS girls with 45,X karyotype, and 32 TS patients with other karyotypes. After DNA extraction, samples were submitted to real-time PCR, using primers and probes directed to the study gene ARSE and to the control gene GAPDH. A ROC curve established the ARSE:GAPDH ratio with a cutoff value of 0.7. Low ARSE:GAPDH ratio of <0.7 was present in 100% of 45,X TS patients. This cutoff value presented a sensitivity of 100% and a specificity of 100% in detecting 45,X TS patients with a positive predictive value of 100% and a negative predictive value of 100%. The same cutoff value was able to identify only 56% of TS with other karyotypes, in which we observed a mean (SD) ARSE:GAPDH ratio=0.66 (0.2); and the interquartile range=0.4–0.8. Determination of ARSE:GAPDH ratio is a fast, sensitive, and specific method, with viable cost and feasible automation, which makes it potentially applicable in neonatal screening programs for the diagnosis of Turner syndrome 45,X.

neonatal screening - ARSE gene - real-time PCR - Turner syndrome

References

• 1 Lippe B. Turner syndrome.  Endocrinol Metab Clin North Am. 1991;  20 121-152
• 2 Gravholt CG, Juul S, Naeraa RW, Hansen J. Morbidity in Turner Syndrome.  J Clin Epidemiol. 1998;  51 147-158
• 3 Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon JP, Craen M, de Zegher F, François I, Du Caju M, Maes M, Heinrichs C. Trends in age at diagnosis of Turner syndrome.  Arch Dis Child. 2005;  90 267-268
• 4 Gicquel C, Gaston V, Cabrol S, Le Bouc Y. Assessment of Turner's syndrome by molecular analysis of the X chromosome in growth-retarded girls.  J Clin Endocrinol Metab. 1998;  83 1472-1476
• 5 Meng H, Hager K, Rivkees SA, Gruen JR. Detection of Turner syndrome using High-throughput quantitative genotyping.  J Clin Endocrinol Metab. 2005;  90 3419-3422
• 6 Cirigliano V, Voglino G, Cañadas MP, Marongiu A, Ejarque M, Ordoñez E, Plaja A, Massobrio M, Todros T, Fuster C, Campogrande M, Egozcue J, Adinolfi M. Rapid prenatal diagnosis of common chromosome aneuploidies by QF-PCR. Assessment on 18 000 consecutive clinical samples.  Mol Human Rep. 2004;  10 839-846
• 7 Longui CA, Rocha MN, Martinho LCAP, Gomes GG, de Miranda RE, Lima TA, Melo MB, Monte O. Molecular detection of XO – Turner syndrome.  Genet Mol Research. 2002;  3 266-270
• 8 Rocha MN, Melo MR, Longui CA, de Oliveira DV, Figueiredo CC, Pacchi PR. A three-step molecular protocol employing DNA obtained from dried blood spots for neonatal screening for 45,X Turner syndrome.  Genet Mol Research. 2005;  4 749-754
• 9 Figueiredo CC, Kochi C, Longui CA, Rocha MN, Richeti F, Evangelista NM, Calliari LE, Monte O. Size of the exon 1-CAG repeats of the androgen receptor gene employed as molecular marker in the diagnosis of Turner syndrome in girls with short stature.  Genet Mol Research. 2008;  7 43-49
• 10 Meroni G, Franco B, Archidiacono N, Messali S, Andolfi G, Rocchi M, Ballabio A. Characterization of a cluster of sulfatase genes on Xp22.3 suggests gene duplication in an ancestral pseudoautosomal region.  Human Mol Genet. 1996;  5 423-431
• 11 Zimmermann B, Holzgreve W, Wenzel F, Hahn S. Novel real-time quantitative PCR test for trisomy 21.  Clin Chem. 2002;  48 362-363

Correspondence